Medication info
Telodipine Tablets 80/5 mg

Telodipine Tablets 80/5 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.935mg / 1 tabletTelmisartan›80mg / 1 tablet
Manufacturer / importer
PharmGen Science Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets (10 tablets/blister x 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201605749 · Approved 2016.09.30 · Insurance code 670104070

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, treatment should be started at a lower dose and the dose increased gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
PharmGen Science Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure that places a strain on the cardiovascular system. In cases where blood pressure cannot be adequately controlled with just Telmisartan or Amlodipine monotherapy, additional treatment may be necessary. This medication helps to effectively control blood pressure in such situations to reduce the risk of cardiovascular complications. Therefore, it is used for blood pressure management in patients with essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, treatment should be started at a lower dose and the dose increased gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it can pose serious risks to the fetus. This drug should not be administered to patients with allergies to its components, pregnant or breastfeeding women, or patients with severe liver or heart problems. Patients with impaired liver function or cholestatic disease should use this medication cautiously, and dosage adjustments may be necessary. Patients with very low blood pressure, severe heart failure, or unstable conditions following acute myocardial infarction should also avoid using this medication. Side effects such as dizziness and edema may commonly occur, and severe side effects may also rarely occur. If any unusual symptoms appear, consult a doctor immediately. Due to the blood pressure-lowering effect, hypotension may occur, so special caution is required for patients who are particularly deficient in fluids or salt. While taking this medication, potassium levels in the blood may increase, so patients at risk of hyperkalemia should undergo regular blood tests. Patients with impaired kidney function should also frequently monitor kidney status and electrolyte levels through blood tests. This medication may interact with other antihypertensive agents or certain drugs, so it is essential to inform the doctor of all medications being taken. In particular, combining this medication with grapefruit juice may excessively increase the blood pressure-lowering effect, so it is advisable to avoid it. This medication is not recommended for breastfeeding women, and if one is breastfeeding, it should be avoided. The safety and efficacy of this medication in children and adolescents under 18 years have not been sufficiently established, so it is advisable not to use it in this population. When administrating to the elderly, it is important to initiate treatment cautiously and adjust the dosage slowly while carefully observing for possible side effects. In the case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate medical attention should be sought for appropriate treatment. This medication should be stored out of the reach of children and kept sealed to protect from moisture.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscular rigidity
  • visual impairment
  • dizziness
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver dysfunction
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic epidermal necrolysis
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased serum creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • vasculitis
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that does not allow light to enter. Additionally, it is important to maintain a room temperature of between 1 and 30 degrees Celsius while storing the medication to retain its effectiveness.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets (10 tablets/blister x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.